Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Altchek's diagnosis and management of ovarian disorders / / edited by Liane Deligdisch, Nathan G. Kase, Carmel J. Cohen [[electronic resource]]
| Altchek's diagnosis and management of ovarian disorders / / edited by Liane Deligdisch, Nathan G. Kase, Carmel J. Cohen [[electronic resource]] |
| Edizione | [Third edition.] |
| Pubbl/distr/stampa | Cambridge : , : Cambridge University Press, , 2013 |
| Descrizione fisica | 1 online resource (xi, 467 pages) : digital, PDF file(s) |
| Disciplina | 618.1/1 |
| Collana | Cambridge medicine |
| Soggetto topico | Ovaries - Diseases |
| ISBN |
1-107-27237-8
1-316-08945-2 1-107-27836-8 1-107-27510-5 1-107-27387-0 1-139-00325-9 1-107-27713-2 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Contents; Contributors; Preface; 1. The normal human ovary part I: reproductive and endocrine functions; Introduction; General principles; Gonadotropin (endocrine) and follicle-dependent (intracrine) factors determine follicle "destiny"; "The molecular players": extrinsic and intrinsic factors in ovarian cycle functions; The major "intrinsic" follicle regulators (Fig. 1.3); The TGF-β superfamily; Intra-ovarian roles of TGF-β superfamily members; Anti-Mullerian hormone; Inhibin/activin system; Integration of the activin/inhibin system in follicle development (Fig. 1.4); Growth factors
Insulin-like growth factors (IGF-1 and IGF-2)The intrinsic IGF system in follicle development and function; Steroids; Estradiol; Progesterone; Conclusion: intrinsic factors at work; Extrinsic factors (Fig. 1.7); The Kisspeptin/GPR54 (KISS1 receptor) system; Gonadotropin-releasing hormone (GnRH); Anterior pituitary gonadotropin secretion; The intracrine role of activin/inhibin system gonadotropin release patterns; Regulatory mechanisms of gonadotropins controlling follicle growth, differentiation, and readiness for ovulation [35]; Gonadal formation and folliculogenesis The development of the ovaryPrimordial germ cells; Transition of oogonia to oocytes and formation of primordial follicles; Formation of primordial follicles; Dormancy and survival of mammalian primordial follicles; Follicle development from arrest to early antral formation; Activation of arrested primordial follicles and transition to primary follicles; "Reactivation" from arrest: reversal of inhibition; TGF-β superfamily promotion of primordial to primary follicle transition (Fig. 1.10); Theca/stroma-derived BMPs; Oocyte-derived TGF-β ligands [67,68] Pregranulosa cell inhibition by anti-Mullerian hormoneGrowth factors and cytokines (Fig. 1.10); A "fixed oocyte endowment" versus oogonia stem cell "reserve"; Progression of primary follicles to early antral stage (Fig. 1.11) [2,3]; TGF-β superfamily regulators [76]; Oocyte-derived GDF-9 and BMP-15; Theca cell participation; Granulosa cell activin/inhibin; TGF-β from oocyte and theca cells; AMH; Growth factors; FSH; Follicle development from antral stage to ovulation; The emergence of FSH dependence: the feedback system and puberty; The feedback system; The hypothalamus and anterior pituitary Ovarian steroidsThe ontogeny of the hypothalamic-pituitary-ovarian axis (Fig. 1.12); Leptin; Puberty; The menstrual cycle: from arrest to ovulation; Follicle development: selection of the dominant follicle; The FSH-dependent stage (3); The stimulatory phase: rising FSH; Phase of FSH decline (Fig. 1.15); Ovulation; Mechanisms of ovulation; LH; Progesterone; Endocrine effects of progesterone; Intra-follicular effects of progesterone; Acceleration and completion of meiosis 1; Prostaglandins; The role FSH; Summary: the importance of H-P-O synchrony in ovulation; The corpus luteum The transformation of the dominant follicle to a corpus luteum |
| Altri titoli varianti | Altchek's Diagnosis & Management of Ovarian Disorders |
| Record Nr. | UNINA-9910452499003321 |
| Cambridge : , : Cambridge University Press, , 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Altchek's diagnosis and management of ovarian disorders / / edited by Liane Deligdisch, Nathan G. Kase, Carmel J. Cohen [[electronic resource]]
| Altchek's diagnosis and management of ovarian disorders / / edited by Liane Deligdisch, Nathan G. Kase, Carmel J. Cohen [[electronic resource]] |
| Edizione | [Third edition.] |
| Pubbl/distr/stampa | Cambridge : , : Cambridge University Press, , 2013 |
| Descrizione fisica | 1 online resource (xi, 467 pages) : digital, PDF file(s) |
| Disciplina | 618.1/1 |
| Collana | Cambridge medicine |
| Soggetto topico | Ovaries - Diseases |
| ISBN |
1-107-27237-8
1-316-08945-2 1-107-27836-8 1-107-27510-5 1-107-27387-0 1-139-00325-9 1-107-27713-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Contents; Contributors; Preface; 1. The normal human ovary part I: reproductive and endocrine functions; Introduction; General principles; Gonadotropin (endocrine) and follicle-dependent (intracrine) factors determine follicle "destiny"; "The molecular players": extrinsic and intrinsic factors in ovarian cycle functions; The major "intrinsic" follicle regulators (Fig. 1.3); The TGF-β superfamily; Intra-ovarian roles of TGF-β superfamily members; Anti-Mullerian hormone; Inhibin/activin system; Integration of the activin/inhibin system in follicle development (Fig. 1.4); Growth factors
Insulin-like growth factors (IGF-1 and IGF-2)The intrinsic IGF system in follicle development and function; Steroids; Estradiol; Progesterone; Conclusion: intrinsic factors at work; Extrinsic factors (Fig. 1.7); The Kisspeptin/GPR54 (KISS1 receptor) system; Gonadotropin-releasing hormone (GnRH); Anterior pituitary gonadotropin secretion; The intracrine role of activin/inhibin system gonadotropin release patterns; Regulatory mechanisms of gonadotropins controlling follicle growth, differentiation, and readiness for ovulation [35]; Gonadal formation and folliculogenesis The development of the ovaryPrimordial germ cells; Transition of oogonia to oocytes and formation of primordial follicles; Formation of primordial follicles; Dormancy and survival of mammalian primordial follicles; Follicle development from arrest to early antral formation; Activation of arrested primordial follicles and transition to primary follicles; "Reactivation" from arrest: reversal of inhibition; TGF-β superfamily promotion of primordial to primary follicle transition (Fig. 1.10); Theca/stroma-derived BMPs; Oocyte-derived TGF-β ligands [67,68] Pregranulosa cell inhibition by anti-Mullerian hormoneGrowth factors and cytokines (Fig. 1.10); A "fixed oocyte endowment" versus oogonia stem cell "reserve"; Progression of primary follicles to early antral stage (Fig. 1.11) [2,3]; TGF-β superfamily regulators [76]; Oocyte-derived GDF-9 and BMP-15; Theca cell participation; Granulosa cell activin/inhibin; TGF-β from oocyte and theca cells; AMH; Growth factors; FSH; Follicle development from antral stage to ovulation; The emergence of FSH dependence: the feedback system and puberty; The feedback system; The hypothalamus and anterior pituitary Ovarian steroidsThe ontogeny of the hypothalamic-pituitary-ovarian axis (Fig. 1.12); Leptin; Puberty; The menstrual cycle: from arrest to ovulation; Follicle development: selection of the dominant follicle; The FSH-dependent stage (3); The stimulatory phase: rising FSH; Phase of FSH decline (Fig. 1.15); Ovulation; Mechanisms of ovulation; LH; Progesterone; Endocrine effects of progesterone; Intra-follicular effects of progesterone; Acceleration and completion of meiosis 1; Prostaglandins; The role FSH; Summary: the importance of H-P-O synchrony in ovulation; The corpus luteum The transformation of the dominant follicle to a corpus luteum |
| Altri titoli varianti | Altchek's Diagnosis & Management of Ovarian Disorders |
| Record Nr. | UNINA-9910779990303321 |
| Cambridge : , : Cambridge University Press, , 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Altchek's diagnosis and management of ovarian disorders / / edited by Liane Deligdisch, Nathan G. Kase, Carmel J. Cohen [[electronic resource]]
| Altchek's diagnosis and management of ovarian disorders / / edited by Liane Deligdisch, Nathan G. Kase, Carmel J. Cohen [[electronic resource]] |
| Edizione | [Third edition.] |
| Pubbl/distr/stampa | Cambridge : , : Cambridge University Press, , 2013 |
| Descrizione fisica | 1 online resource (xi, 467 pages) : digital, PDF file(s) |
| Disciplina | 618.1/1 |
| Collana | Cambridge medicine |
| Soggetto topico | Ovaries - Diseases |
| ISBN |
1-107-27237-8
1-316-08945-2 1-107-27836-8 1-107-27510-5 1-107-27387-0 1-139-00325-9 1-107-27713-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Contents; Contributors; Preface; 1. The normal human ovary part I: reproductive and endocrine functions; Introduction; General principles; Gonadotropin (endocrine) and follicle-dependent (intracrine) factors determine follicle "destiny"; "The molecular players": extrinsic and intrinsic factors in ovarian cycle functions; The major "intrinsic" follicle regulators (Fig. 1.3); The TGF-β superfamily; Intra-ovarian roles of TGF-β superfamily members; Anti-Mullerian hormone; Inhibin/activin system; Integration of the activin/inhibin system in follicle development (Fig. 1.4); Growth factors
Insulin-like growth factors (IGF-1 and IGF-2)The intrinsic IGF system in follicle development and function; Steroids; Estradiol; Progesterone; Conclusion: intrinsic factors at work; Extrinsic factors (Fig. 1.7); The Kisspeptin/GPR54 (KISS1 receptor) system; Gonadotropin-releasing hormone (GnRH); Anterior pituitary gonadotropin secretion; The intracrine role of activin/inhibin system gonadotropin release patterns; Regulatory mechanisms of gonadotropins controlling follicle growth, differentiation, and readiness for ovulation [35]; Gonadal formation and folliculogenesis The development of the ovaryPrimordial germ cells; Transition of oogonia to oocytes and formation of primordial follicles; Formation of primordial follicles; Dormancy and survival of mammalian primordial follicles; Follicle development from arrest to early antral formation; Activation of arrested primordial follicles and transition to primary follicles; "Reactivation" from arrest: reversal of inhibition; TGF-β superfamily promotion of primordial to primary follicle transition (Fig. 1.10); Theca/stroma-derived BMPs; Oocyte-derived TGF-β ligands [67,68] Pregranulosa cell inhibition by anti-Mullerian hormoneGrowth factors and cytokines (Fig. 1.10); A "fixed oocyte endowment" versus oogonia stem cell "reserve"; Progression of primary follicles to early antral stage (Fig. 1.11) [2,3]; TGF-β superfamily regulators [76]; Oocyte-derived GDF-9 and BMP-15; Theca cell participation; Granulosa cell activin/inhibin; TGF-β from oocyte and theca cells; AMH; Growth factors; FSH; Follicle development from antral stage to ovulation; The emergence of FSH dependence: the feedback system and puberty; The feedback system; The hypothalamus and anterior pituitary Ovarian steroidsThe ontogeny of the hypothalamic-pituitary-ovarian axis (Fig. 1.12); Leptin; Puberty; The menstrual cycle: from arrest to ovulation; Follicle development: selection of the dominant follicle; The FSH-dependent stage (3); The stimulatory phase: rising FSH; Phase of FSH decline (Fig. 1.15); Ovulation; Mechanisms of ovulation; LH; Progesterone; Endocrine effects of progesterone; Intra-follicular effects of progesterone; Acceleration and completion of meiosis 1; Prostaglandins; The role FSH; Summary: the importance of H-P-O synchrony in ovulation; The corpus luteum The transformation of the dominant follicle to a corpus luteum |
| Altri titoli varianti | Altchek's Diagnosis & Management of Ovarian Disorders |
| Record Nr. | UNINA-9910809056403321 |
| Cambridge : , : Cambridge University Press, , 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Current management of polycystic ovary syndrome / / edited by Adam Balen [and others] [[electronic resource]]
| Current management of polycystic ovary syndrome / / edited by Adam Balen [and others] [[electronic resource]] |
| Pubbl/distr/stampa | London : , : RCOG Press, , 2010 |
| Descrizione fisica | 1 online resource (ix, 227 pages) : digital, PDF file(s) |
| Disciplina | 618.1/1 |
| Soggetto topico | Polycystic ovary syndrome |
| ISBN |
1-107-71102-9
1-107-71445-1 9786613269065 1-283-26906-6 1-906985-51-0 1-107-47834-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910463266103321 |
| London : , : RCOG Press, , 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Current management of polycystic ovary syndrome / / edited by Adam Balen [and others] [[electronic resource]]
| Current management of polycystic ovary syndrome / / edited by Adam Balen [and others] [[electronic resource]] |
| Pubbl/distr/stampa | London : , : RCOG Press, , 2010 |
| Descrizione fisica | 1 online resource (ix, 227 pages) : digital, PDF file(s) |
| Disciplina | 618.1/1 |
| Soggetto topico | Polycystic ovary syndrome |
| ISBN |
1-107-71102-9
1-107-71445-1 9786613269065 1-283-26906-6 1-906985-51-0 1-107-47834-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910787985103321 |
| London : , : RCOG Press, , 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Current management of polycystic ovary syndrome / / edited by Adam H. Balen ...[et. al.]
| Current management of polycystic ovary syndrome / / edited by Adam H. Balen ...[et. al.] |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | London, : RCOG, 2010 |
| Descrizione fisica | 1 online resource (ix, 227 pages) : digital, PDF file(s) |
| Disciplina | 618.1/1 |
| Altri autori (Persone) | BalenAdam |
| Soggetto topico |
Polycystic ovary syndrome
Ovaries - Cysts |
| ISBN |
1-107-71102-9
1-107-71445-1 9786613269065 1-283-26906-6 1-906985-51-0 1-107-47834-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title page -- Contents -- Participants -- Additional contributors -- Declarations of personal interest -- Preface -- 1 Overview and definitions of polycystic ovary syndrome and the polycystic ovary -- Introduction -- What is polycystic ovary syndrome? -- Defining the polycystic ovary: historical and histopathological considerations -- Ultrasound descriptions of the polycystic ovary -- Multicystic and polycystic ovaries -- Transvaginal ultrasound -- Stromal echogenicity -- Three-dimensional ultrasound, Doppler and MRI -- Exclusion of related disorders -- Conclusion -- Key points -- References -- 2 Genetics and pathogenesis of polycystic ovary syndrome -- Introduction -- Developmental origin of PCOS -- Genes and PCOS -- Role of the intrauterine environment -- Role of the external environment: diet, obesity and PCOS -- Summary -- References -- 3 Ethnic variations in the expression of polycystic ovary syndrome -- Introduction -- Defining race and ethnicity -- Evidence for ethnic variations in the expression of PCOS -- Historical background -- Ethnic variations of obesity, insulin resistance and the metabolic syndrome in PCOS -- The Asian perspective -- Non-Asians -- Ethnic variation of hyperandrogenism in PCOS -- East Asians -- Other ethnic groups -- Ethnic interrelationships of metabolic problems and hyperandrogenism manifestations of PCOS -- Epidemiological variations of insulin resistance and the prevalence of PCOS - are they in parallel? -- Ethnic differences in diagnostic thresholds for polycystic ovaries -- Ethnic differences in quality of life -- Summary and conclusion -- Acknowledgements -- References -- 4 Quality of life for women with polycystic ovary syndrome -- Introduction -- What is health-related quality of life? -- Measuring HRQoL -- Types of instrument available to measure quality of life in women with PCOS.
Generic questionnaires -- Overall impact of PCOS on HRQoL -- Comparisons with controls (other gynaecological populations) -- PCOS and mental health -- Impact of PCOS-associated obesity on HRQoL -- Problems with proxy assessments of HRQoL -- Impact of PCOS-associated infertility and sexual functioning on HRQoL -- Treatments for PCOS that have measured associated changes to HRQoL -- Conclusion -- Summary of key points -- References -- 5 Insulin resistance, the metabolic syndrome and polycystic ovary syndrome -- Introduction -- Definitions and diagnosis -- Mechanism of insulin resistance in PCOS -- Interactions between the metabolic syndrome and ovarian function -- Insulin as a co-gonadotrophin -- Inflammation and the ovary -- PCOS as a marker for type 2 diabetes -- PCOS as a marker for cardiovascular disease -- PCOS and non-alcoholic steatohepatitis -- PCOS and implications for family members -- Treatment of PCOS and the metabolic syndrome -- Conclusion -- References -- 6 Management of polycystic ovary syndrome through puberty and adolescence -- Introduction -- Diagnosis -- The menstrual cycle during adolescence -- Ovarian appearance on ultrasound -- Hormonal changes during puberty -- Clinical presentation -- Developmental origins of PCOS -- Differential diagnosis -- Treatment -- Oral contraceptive pills -- Metformin -- Thiazolidinediones -- Antiandrogens -- Recommendations -- Clinical evaluation -- Investigations -- Treatment -- Monitoring -- Conclusion -- References -- 7 Long-term health risks of polycystic ovary syndrome -- Increased cardiovascular risk -- Surrogates for cardiovascular disease -- Traditional measures and the metabolic syndrome -- New markers -- Waist circumference and HDL cholesterol -- PCOS as a risk factor on its own -- Recommendations -- Risk for type 2 diabetes and impaired glucose tolerance -- Complications of obesity. Gynaecological malignancies -- Endometrial hyperplasia and cancer -- Breast cancer -- Ovarian cancer -- Conclusion -- References -- 8 Approaches to lifestyle management in polycystic ovary syndrome -- Introduction -- Prevalence of obesity and PCOS -- Evidence that early weight gain favours the development of PCOS -- Pathophysiological aspects of adipose tissue in PCOS -- Obesity worsens the PCOS phenotype and associated metabolic alterations -- Treatment of obesity improves PCOS -- Lifestyle management -- Lifestyle modification and infertility -- Conclusion -- References -- 9 Management of obesity in polycystic ovary syndrome, including anti-obesity drugs and bariatric surgery -- Introduction -- Lifestyle modification -- Anti-obesity medication -- Orlistat -- Sibutramine -- Bariatric surgery -- Background -- Bariatric surgery and PCOS -- Pregnancy after bariatric surgery -- Conclusion -- References -- 10 Definition of hyperandrogenism -- Clinical hyperandrogenism -- Biochemical hyperandrogenism -- Assessment of anovulation -- Proposal for new criteria -- Clinical hyperandrogenism -- Laboratory hyperandrogenism -- Laboratory diagnosis of anovulation -- Summary -- References -- 11 Treatment of hyperandrogenism in polycystic ovary syndrome -- Introduction -- Acne -- General advice -- Managing according to clinical sub-type -- Treatment of non-inflammatory lesions -- Treatment of mild to moderate inflammatory lesions -- Topical therapies for post-inflammatory hyperpigmentation -- Alternative therapies and procedures -- Nodular lesions -- Non-inflammatory lesions -- Skincare and use of cosmetics -- Systemic therapies -- Inhibitors of adrenal androgen production -- Inhibitors of ovarian androgen production -- Oral contraceptives -- Gonadotrophin-releasing hormone agonists -- Androgen receptor blockers -- Spironolactone -- Flutamide -- Finasteride. Insulin-sensitising drugs -- Conclusion on acne management in PCOS -- Hirsutism -- Topical therapy -- Eflornithine hydrochloride -- Systemic therapy -- COC pills -- Cyproterone acetate -- Spironolactone -- Gonadotrophin-releasing hormone agonists -- Finasteride -- Flutamide -- Insulin-sensitising drugs -- Female-pattern hair loss -- Minoxidil -- Antiandrogens -- Reductase inhibitors -- Conclusion -- References -- 12 Choices in the treatment of anovulatory polycystic ovary syndrome -- Introduction -- Weight loss -- Clomifene citrate -- Mode of action -- Dose -- Results -- Clomifene citrate treatment failure -- Monitoring -- Adjuvant treatment -- Aromatase inhibitors -- Mode of action -- Indications -- Dose -- Evidence -- Safety -- Metformin -- Mode of action -- Dose -- Evidence -- Safety -- Low-dose gonadotrophin therapy -- Principle -- Regimen -- Evidence -- Variations -- References -- 13 Predictors of ovarian response to ovarian stimulation: progress towards individualised treatment in ovulation induction -- Introduction -- Predictors of ovarian response in ovulation induction -- Predicting response to anti-estrogen therapy -- Predicting response to gonadotrophins -- Might genetic predictors be useful? -- Conclusion -- References -- 14 Surgical management of anovulatory infertility in polycystic ovary syndrome -- Introduction -- History -- Methods and dose -- Risks of adhesion formation and ovarian failure -- Endocrine changes after laparoscopic ovarian surgery -- Pregnancy rates -- Transvaginal approach -- Summary -- Key points -- Clinical practice points -- Future avenues for research -- References -- 15 The role of insulin-sensitising drugs in the treatment of polycystic ovary syndrome -- Introduction -- Metformin -- Premature pubarche -- Infertility -- Miscarriage and pregnancy complications -- Hirsutism -- Diabetes prevention. Endometrial cancer prevention -- Conclusion -- Acknowledgements -- References -- 16 The role of in vitro maturation of oocytes for anovulatory polycystic ovary syndrome -- In vitro maturation of immature oocytes -- Variations -- Patient selection -- hCG priming -- Gonadotrophin ovarian stimulation -- ICSI -- Endometrial priming -- Metformin co-treatment -- Timing of immature oocyte retrieval in relation to follicular diameter -- Results -- Safety -- Summary -- References -- 17 Acupuncture and/or herbal therapy as an alternative or complement for relief of polycystic ovary syndrome-related symptoms -- Introduction -- Treatment of PCOS -- The physiological basis for acupuncture -- How may acupuncture act in women with PCOS? -- Evidence for the use of acupuncture in PCOS -- Effects on ovulation -- Effects on metabolic abnormalities -- Effects on mental health -- Effects on the sympathetic nervous system -- Continuing or completed RCTs on the effects of acupuncture in PCOS-related symptoms -- Herbal therapy for the relief of PCOS-related symptoms -- Herbs for ovulation induction -- Vitex agnus-castus -- White peony -- Sairei-to -- Mentha spicata Labiatae -- Herbs for metabolic abnormalities -- Berberine -- Cinnamon -- Labisia pumila -- Future perspectives -- Conclusion -- References -- 18 Consensus views arising from the 59th Study Group: Current Management of Polycystic Ovary Syndrome -- Diagnosis/pathophysiology -- Management -- Lifestyle and metabolic aspects -- Treatments -- Research -- Index. |
| Record Nr. | UNINA-9910819029003321 |
| London, : RCOG, 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Endocrine physiopathology of the ovary : proceedings of the International Symposium on Endocrine Physiopathology of the Ovary, held in Rosario, Argentina, 23-26 May, 1979 / / editors, R. I. Tozzini, G. Reeves, and R. L. Pineda
| Endocrine physiopathology of the ovary : proceedings of the International Symposium on Endocrine Physiopathology of the Ovary, held in Rosario, Argentina, 23-26 May, 1979 / / editors, R. I. Tozzini, G. Reeves, and R. L. Pineda |
| Pubbl/distr/stampa | Amsterdam ; ; New York, : Elsevier/North-Holland Biomedical Press : sole distributors for the U.S.A. and Canada, Elsevier North-Holland, 1980 |
| Descrizione fisica | viii, 383 p. : ill. ; ; 25 cm |
| Disciplina |
618.1/1
618.11 $v 23 |
| Altri autori (Persone) |
Tozzini, R. I
Reeves, Guillermo Pineda, R. L (Rafael Luis) |
| Soggetto non controllato |
Ovaries
Endocrine gynecology Anovulation Ovulation Overy Endocrinology |
| ISBN | 0444802142 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910588390003321 |
| Amsterdam ; ; New York, : Elsevier/North-Holland Biomedical Press : sole distributors for the U.S.A. and Canada, Elsevier North-Holland, 1980 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Management of adnexal mass
| Management of adnexal mass |
| Pubbl/distr/stampa | [Place of publication not identified], : AHRQ, 2006 |
| Descrizione fisica | 1 online resource |
| Disciplina | 618.1/1 |
| Collana |
Evidence Reports/Technology Assessments
AHRQ publication |
| Soggetto topico |
Endocrine Gland Neoplasms
Ovarian Diseases Cysts Evidence-Based Practice Clinical Medicine Genital Neoplasms, Female Medicine Adnexal Diseases Neoplasms Gonadal Disorders Endocrine System Diseases Health Occupations Neoplasms by Site Urogenital Neoplasms Female Urogenital Diseases Diseases Genital Diseases, Female Female Urogenital Diseases and Pregnancy Complications Evidence-Based Medicine Ovarian Neoplasms Ovarian Cysts Health & Biological Sciences Gynecology & Obstetrics |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910698292303321 |
| [Place of publication not identified], : AHRQ, 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Ovarian hyperstimulation syndrome : epidemiology, pathophysiology, prevention and management / / Botros R.M.B. Rizk [[electronic resource]]
| Ovarian hyperstimulation syndrome : epidemiology, pathophysiology, prevention and management / / Botros R.M.B. Rizk [[electronic resource]] |
| Autore | Rizk Botros |
| Pubbl/distr/stampa | Cambridge : , : Cambridge University Press, , 2006 |
| Descrizione fisica | 1 online resource (xiv, 233 pages) : digital, PDF file(s) |
| Disciplina | 618.1/1 |
| Soggetto topico |
Ovaries - Diseases
Human reproductive technology - Complications |
| ISBN |
1-107-15604-1
1-280-48000-9 9786610480005 0-511-22037-5 0-511-22130-4 0-511-21933-4 0-511-31468-X 0-511-54729-3 0-511-22001-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Classification of Ovarian hyperstimulation syndrome -- Epidemiology of Ovarian hyperstimulation syndrome -- Pathophysiology of Ovarian hyperstimulation syndrome -- Genetics of Ovarian hyperstimulation syndrome -- Complications of Ovarian hyperstimulation syndrome -- Prediction of Ovarian hyperstimulation syndrome -- Prevention of Ovarian hyperstimulation syndrome -- Treatment of Ovarian hyperstimulation syndrome. |
| Record Nr. | UNINA-9910457822103321 |
Rizk Botros
|
||
| Cambridge : , : Cambridge University Press, , 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Ovarian hyperstimulation syndrome : epidemiology, pathophysiology, prevention and management / / Botros R.M.B. Rizk [[electronic resource]]
| Ovarian hyperstimulation syndrome : epidemiology, pathophysiology, prevention and management / / Botros R.M.B. Rizk [[electronic resource]] |
| Autore | Rizk Botros |
| Pubbl/distr/stampa | Cambridge : , : Cambridge University Press, , 2006 |
| Descrizione fisica | 1 online resource (xiv, 233 pages) : digital, PDF file(s) |
| Disciplina | 618.1/1 |
| Soggetto topico |
Ovaries - Diseases
Human reproductive technology - Complications |
| ISBN |
1-107-15604-1
1-280-48000-9 9786610480005 0-511-22037-5 0-511-22130-4 0-511-21933-4 0-511-31468-X 0-511-54729-3 0-511-22001-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Classification of Ovarian hyperstimulation syndrome -- Epidemiology of Ovarian hyperstimulation syndrome -- Pathophysiology of Ovarian hyperstimulation syndrome -- Genetics of Ovarian hyperstimulation syndrome -- Complications of Ovarian hyperstimulation syndrome -- Prediction of Ovarian hyperstimulation syndrome -- Prevention of Ovarian hyperstimulation syndrome -- Treatment of Ovarian hyperstimulation syndrome. |
| Record Nr. | UNINA-9910784336503321 |
|
Rizk Botros
|
||
| Cambridge : , : Cambridge University Press, , 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
